0001209191-21-018569.txt : 20210308
0001209191-21-018569.hdr.sgml : 20210308
20210308163806
ACCESSION NUMBER: 0001209191-21-018569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210304
FILED AS OF DATE: 20210308
DATE AS OF CHANGE: 20210308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kosacz Barbara
CENTRAL INDEX KEY: 0001763316
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39503
FILM NUMBER: 21722452
MAIL ADDRESS:
STREET 1: 3175 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athira Pharma, Inc.
CENTRAL INDEX KEY: 0001620463
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 453368487
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: (206) 221-8112
MAIL ADDRESS:
STREET 1: 18706 NORTH CREEK PARKWAY, SUITE 104
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: M3 Biotechnology, Inc.
DATE OF NAME CHANGE: 20140924
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-04
0
0001620463
Athira Pharma, Inc.
ATHA
0001763316
Kosacz Barbara
C/O ATHIRA PHARMA, INC.
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL
WA
98011
1
0
0
0
Stock Option (Right to Buy)
19.29
2021-03-04
4
A
0
27742
0.00
A
2031-03-03
Common Stock
27742
27742
D
One thirty-sixth of the shares subject to the option will vest on April 4, 2021 and one thirty-sixth of the shares subject to the option will vest each month thereafter.
Glenna Mileson, Attorney in fact for Barbara Kosacz
2021-03-08